Search company, investor...

Cardiac Insight

cardiacinsightinc.com

Founded Year

2008

Stage

Debt - IV | Alive

Total Raised

$40.21M

Last Raised

$11.6M | 8 mos ago

About Cardiac Insight

Cardiac Insight is focused on developing advanced body-worn sensing and computing technologies for diagnostic testing in cardiology, respiratory, and other complex disease states. The company seeks to do more than incrementally improve diagnostics and treatment, but rather to invent complete solutions to unmet clinical needs.On March 16th, 2022, Cardiac Insight was acquired by DreamTech. The terms of the transaction were not disclosed.

Headquarters Location

2375 130th Ave. NE Suite 101

Bellevue, Washington, 98005,

United States

866-554-3751

Missing: Cardiac Insight's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cardiac Insight's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cardiac Insight

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cardiac Insight is included in 6 Expert Collections, including Wearable Computing.

W

Wearable Computing

415 items

Wearable computing is broadly defined as companies developing devices worn or placed on the body that are equipped with technology, which can range from wearable medical devices to AR/VR headsets to GPS pet collars.

M

Medical Devices

11,890 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,836 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,428 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

T

Telehealth

2,854 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health IT

8,881 items

Cardiac Insight Patents

Cardiac Insight has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Congenital heart defects
  • Cardiac electrophysiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/12/2020

1/11/2022

Medical monitoring equipment, Cardiac procedures, Electrical safety, Electric power distribution, Electrical engineering

Grant

Application Date

6/12/2020

Grant Date

1/11/2022

Title

Related Topics

Medical monitoring equipment, Cardiac procedures, Electrical safety, Electric power distribution, Electrical engineering

Status

Grant

Latest Cardiac Insight News

Cardiac Insight’s Cardea SOLO™ ECG System Named as Finalist in Fierce Innovation Awards Healthcare Edition

Oct 24, 2022

October 24, 2022 01:00 PM Eastern Daylight Time BELLEVUE, Wash.--( BUSINESS WIRE )-- Cardiac Insight, Inc. , a leading healthcare innovator specializing in prescription-based wearable cardiac sensors and automated electrocardiogram (ECG) analysis software for cardiac arrhythmia diagnosis, has been named a finalist in the 2022 Fierce Healthcare Innovation Awards for its Cardea SOLO™ ECG System. The awards recognize innovations that are transforming the healthcare industry. Cardiac Insight’s Cardea SOLO ECG system was selected by a panel of expert judges as a potential winner in the Digital/Mobile Health Solutions category. Every year, the awards receive a tremendous number of entries, and participants are evaluated on such factors as the organization’s unique contribution to healthcare, including solutions that promise to engage patients, improve the quality of care, save money, and revolutionize the industry. Award finalists must also demonstrate effectiveness, technical innovation, and competitive advantage. “We are honored to be selected as a finalist for the Fierce Healthcare Innovation Awards,” said Mr. Min Kim, Chief Executive Officer of Cardiac Insight, Inc. “We are committed to assisting physicians in the early detection of cardiac arrhythmias entirely at the point of patient care. The Cardea SOLO ECG Sensor is exceptionally comfortable for the patient, improving wear-time compliance. For the physician, the Cardea SOLO System enables a completely in-office diagnostic procedure − from prescription to diagnostic confirmation, treatment, and potential specialist referral.” Cardea SOLO is the first standalone ECG system to facilitate timely, cost-effective arrhythmia diagnosis, with the capability to automatically detect and report on over 15 abnormal cardiac rhythms. These include atrial fibrillation, ventricular tachycardia, and other potentially serious arrhythmias. Designed for use in an outpatient setting, the patient wears a cable-free, chest-worn disposable sensor for up to seven days while going about their routine activities, including showers and moderate exercise. The Sensor is returned to the physician practice, and its data transferred to a computer to be read by the Cardea SOLO Analysis Software. In less than five minutes, the software automatically analyzes the ECG data and displays a draft summary report for physician review. The platform enables hospitals, private practice cardiologists and electrophysiologists to eliminate costly ECG report analysis outsourcing that can often be the source of long wait times to get those reports back and potentially delaying patient treatment. Cardea SOLO facilitates improved patient care while keeping patient data securely in-house, enhancing overall healthcare data cybersecurity. The winners of the 2022 Fierce Healthcare Innovation Awards will be announced on November 14th. About Cardiac Insight Cardiac Insight, Inc. is a leading U.S. digital healthcare innovation company specializing in the development of medical-grade, body-worn sensor technology and automated cardiac analysis solutions through its proprietary algorithms and software platforms. The company’s products include the Cardea SOLO™ wearable ECG Sensor and Software Analysis System, and the Cardea 20/20 ECG™ – the only resting 12-Lead ECG System designed for cardiac risk screening in young athletes at all levels of play. For more information, please visit:

Cardiac Insight Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cardiac Insight Rank

Cardiac Insight Frequently Asked Questions (FAQ)

  • When was Cardiac Insight founded?

    Cardiac Insight was founded in 2008.

  • Where is Cardiac Insight's headquarters?

    Cardiac Insight's headquarters is located at 2375 130th Ave. NE, Bellevue.

  • What is Cardiac Insight's latest funding round?

    Cardiac Insight's latest funding round is Debt - IV.

  • How much did Cardiac Insight raise?

    Cardiac Insight raised a total of $40.21M.

  • Who are the investors of Cardiac Insight?

    Investors of Cardiac Insight include DreamTech, Paycheck Protection Program, SeaChange Fund, WINGS - The Medical Technology Angel Network, WRF Capital and 10 more.

  • Who are Cardiac Insight's competitors?

    Competitors of Cardiac Insight include Omron, Eko, VitalConnect, Fresenius Medical Care, Masimo, AliveCor, Biofourmis, EarLens, Hillrom Holdings, Babyscripts and 30 more.

Compare Cardiac Insight to Competitors

AliveCor Logo
AliveCor

AliveCor focuses on the creation of FDA-cleared machine learning techniques to enable proactive heart care. The FDA-cleared KardiaMobile is a clinically validated mobile EKG solution used by people for accurate EKG recordings. KardiaMobile, and KardiaBand, when paired with the Kardia app provide instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an EKG. The firm serves clients operating in the healthcare sector. It was formerly known as AliveUSA. It was founded in 2011 and is based in Mountain View, California.

CareTaker Medical Logo
CareTaker Medical

CareTaker Medical is a wireless patient monitor. It uses only a finger cuff to measure continuous beat-by-beat blood pressure, heart rate, and other physiological parameters enabling remote patient monitoring via its secure Android app, cloud portals, or interfaced with other patient monitoring systems.

VitalConnect Logo
VitalConnect

VitalConnect is specializes in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. It leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions. VitalConnect’s advanced yet easy-to-use platform aims to deliver better healthcare at lower costs while providing more convenience for the patients and healthcare providers. The company was formerly known as Vigilo Networks. It was founded in 2011 and is based in San Jose, California.

Vectorious Medical Technologies Logo
Vectorious Medical Technologies

Vectorious Medical Technologies is developing a cardiac monitoring system for congestive heart failure patients. Vectorious technology helps physicians to help patients help themselves. Via a simple, minimally-invasive implanted device, easy-to-access data and user-friendly external home-unit; the Vectorious system increases CHF patient quality of life and reduces readmission rates.

Bigfoot Biomedical Logo
Bigfoot Biomedical

Bigfoot Biomedical is on a mission to improve the lives of people with insulin-requiring diabetes through the application of smart technology. Bigfoot's approach includes delivering an Internet-of-Things medical device, a cloud-connected system bundled as a monthly subscription service, to a broad population historically challenged by the high upfront costs of traditional insulin delivery hardware.

T
Triple Jump

Triple Jump develops a small insulin pump patch that is placed on the patient’s body. The patch has mobile connectivity capabilities and will be included in a future artificial pancreas system.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.